- Telehealth visits
Sara M. Buckelew, MD, MPH
Adolescent MedicineDirector, Eating Disorders Program- Telehealth visits
Sara M. Buckelew, MD, MPH
Adolescent MedicineDirector, Eating Disorders Program- Telehealth visits
On this page
About me
Dr. Sara M. Buckelew is a specialist in adolescent medicine and a director of the UCSF Eating Disorders Program. Her focus is on caring for teenagers with eating disorders, including anorexia nervosa and bulimia. In research, she also focuses on eating disorders, as well as other topics in adolescent mental health.
Buckelew earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She completed a residency in pediatrics at Children's Hospital Los Angeles and earned a master of public health degree from the University of California, Berkeley. At UCSF, she completed a residency in preventive medicine and public health, followed by a fellowship in adolescent medicine. She is a member of the American College of Preventive Medicine, Association for Prevention Teaching and Research, and Society for Adolescent Health and Medicine.
Buckelew is accepting new patients.
Education & training
Board certification
- Adolescent Medicine, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Adolescent Medicine, UCSF School of Medicine -GME
Residency
- Preventative Medicine, UCSF School of Medicine -GME
- Pediatrics, Childrens Hospital - Los Angeles
Internship
- Pediatrics, Childrens Hospital - Los Angeles
Degree
- MD, University of Pennsylvania School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.